Fogarty International Center; Notice of Meeting, 4963-4964 [E9-1753]
Download as PDF
<![CDATA[
4963
Federal Register / Vol. 74, No. 17 / Wednesday, January 28, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60-Day
Proposed Information Collection:
Indian Health Service Director’s Three
Initiative Best Practice, Promising
Practice, and Local Effort Form
Indian Health Service, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 which requires
60 days for public comment on
proposed information collection
projects, the Indian Health Service (IHS)
is publishing for comment a summary of
a proposed information collection to be
submitted to the Office of Management
and Budget (OMB) for review.
Proposed Collection: Title: 0917–
NEW, ‘‘Indian Health Service Director’s
Three Initiative Best Practice, Promising
Practice, and Local Effort Form.’’ Type
of Information Collection Request:
Three year approval of this new
information collection, 0917–NEW,
‘‘Indian Health Service Director’s Three
Initiative Best Practice, Promising
Practice, and Local Effort (BPPPLE)
Form.’’
Form(s): The Indian Health Service
BPPPLE form. Need and Use of
Information Collection: The Indian
Health Service (IHS) goal is to raise the
health status of the American Indian
and Alaska Native (AI/AN) people to the
highest possible level by providing
comprehensive health care and
preventive health services. To support
the HiS mission, the Director’s Three
Initiative was launched which is
comprised of Health Promotion and
Disease Prevention (HP/DP), Behavioral
Health (BH) and Chronic Care (CC). The
Director’s Three Initiative is linked
together in their aim to reduce health
disparities and improve the health and
wellness among the AI/AN populations
through a coordinated and systematic
approach to enhance health promotion,
and chronic disease and mental health
prevention methods at the local,
regional, and national levels.
To provide the product/service to
IHS, Tribal, and Urban (I/T/U)
programs, the Director’s Three Initiative
work together to develop a centralized
program database of Best/Promising
Practices (BPP). The purpose of this
collection is to develop a database of
BPP to be published on the IHS.gov Web
Number of
respondents
Data collection instrument(s)
site which will be a resource for
program evaluation and for modeling
examples of HP/DP, BH, and CC projects
occurring in AI/AN communities.
This is a request that OMB approves,
under the Paperwork Reduction Act, an
IHS information collection initiative to
promote submission of ‘‘Best and
Promising Practices and Local Efforts’’
among the I/T/U.
All information submitted is on a
voluntary basis; no legal basis exists for
collection of this information.
The information collected will enable
the Director’s Three Initiative program
to: (a) Identify evidence based
approaches to prevention programs
among the I/T/U when no system is
currently in place; and (b) Allow the
program managers to review BPPPLE
occurring among the I/T/U when
considering program planning for their
community.
Affected Public: Individuals. Type of
Respondents: I/T/U organizations
program staff.
The table below provides: Types of
data collection instruments, Number of
respondents, Responses per respondent,
Average burden hour per response, and
Total annual burden hour(s).
Estimated Burden Hours
Responses
per
respondent
Average
burden hour
per response
Total annual
burden hours
100
1
20/60
33.3
Total ..........................................................................................................
sroberts on PROD1PC70 with NOTICES
IHS Service Unit, Tribal, and Urban Indian Center Administrators .................
100
........................
........................
33.3
There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to
report.
Request for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points: (a) Whether the information
collection activity is necessary to carry
out an agency function; (b) whether the
agency processes the information
collected in a useful and timely fashion;
(c) the accuracy of the public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information); (d)
whether the methodology and
assumptions used to determine the
estimates are logical; (e) ways to
enhance the quality, utility, and clarity
of the information being collected; and
(f) ways to minimize the public burden
through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
VerDate Nov<24>2008
17:30 Jan 27, 2009
Jkt 217001
Send Comments and Requests for
Further Information: Send your written
comments, requests for more
information on the proposed collection,
or requests to obtain a copy of the data
collection instrument(s) and
instructions to: Ms. Betty Gould,
Regulations Officer, 801 Thompson
Avenue, TMP, Suite 450, Rockville, MD
20852–1627; call (301) 443–7899; send
via facsimile to (301) 443–9879; or send
your e-mail requests, comments, and
return address to: betty.gould@ihs.gov.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 60 days of the date of
this publication.
Dated: January 21, 2009.
Robert G. McSwain,
Director, Indian Health Service.
[FR Doc. E9–1794 Filed 1–27–09; 8:45 am]
BILLING CODE 4165–16–M
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Fogarty International Center Advisory
Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\28JAN1.SGM
28JAN1
4964
Federal Register / Vol. 74, No. 17 / Wednesday, January 28, 2009 / Notices
sroberts on PROD1PC70 with NOTICES
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Fogarty International
Center Advisory Board.
Date: February 9–10, 2009.
Closed: February 9, 2009, 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Lawton Chiles International House, Bethesda,
MD 20892.
Closed: February 10, 2009, 8:30 a.m. to
10:30 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Lawton Chiles International House, Bethesda,
MD 20892.
Open: February 10, 2009, 10:30 a.m. to 5
p.m.
Agenda: Topics of the meeting include: (1)
The implementation of the FIC Strategic
Plan; (2) FIG regional priorities; (3) the role
of U.S. diplomatic priorities in planning
global programs; and (4) priorities for publicprivate partnerships.
Place: National Institutes of Health,
Lawton Chiles International House, Bethesda,
MD 20892.
Contact Person: Robert Eiss, Public Health
Advisor, Fogarty International Center,
National Institutes of Health, 31 Center Drive,
Room B2C02, Bethesda, MD 20892, (301)
496–1415, EISSR@MAIL.NIH.GOV.
This meeting is being published less than
15 days prior to the meeting due to timing
limitations imposed by administrative
matters.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, drivers license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nih.gov/fic/about/advisory.html, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.106, Minority International
Research Training Grant in the Biomedical
and Behavioral Sciences; 93.154, Special
International Postdoctoral Research Program
VerDate Nov<24>2008
17:30 Jan 27, 2009
Jkt 217001
in Acquired lmmunodeficiency Syndrome;
93.168, International Cooperative
Biodiversity Groups Program; 93.934, Fogarty
International Research Collaboration Award;
93.989, Senior International Fellowship
Awards Program, National Institutes of
Health, HHS)
Dated: January 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–1753 Filed 1–27–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Bacillus Anthracis Program
Project.
Date: February 19, 2009.
Time: 12 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B Rockledge Drive, Room 3122, Bethesda,
MD 20817, (Telephone Conference Call).
Contact Person: Brenda Lange-Gustafson,
PhD, Scientific Review Officer, NIAID/NIH/
DHHS, Scientific Review Program, Room
3122, 6700-B Rockledge Drive, MSC–7616,
Bethesda, MD 20892–7616, 301–451–3684,
bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–1856 Filed 1–27–09; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Eicosanoids in
Renal Function Program Projects.
Date: March 3, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Atul Sahai, PhD, Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
759, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–2242,
sahaia@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Trafficking in
Polarized Epithelial Cells.
Date: April 7, 2009.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Maria E. Davila-Bloom,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 758, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 74, Number 17 (Wednesday, January 28, 2009)]
[Notices]
[Pages 4963-4964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-1753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Fogarty International Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Fogarty International Center Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 4964]]
as amended. The grant applications and/or contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and/or
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Fogarty International Center Advisory Board.
Date: February 9-10, 2009.
Closed: February 9, 2009, 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Lawton Chiles
International House, Bethesda, MD 20892.
Closed: February 10, 2009, 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Lawton Chiles
International House, Bethesda, MD 20892.
Open: February 10, 2009, 10:30 a.m. to 5 p.m.
Agenda: Topics of the meeting include: (1) The implementation of
the FIC Strategic Plan; (2) FIG regional priorities; (3) the role of
U.S. diplomatic priorities in planning global programs; and (4)
priorities for public-private partnerships.
Place: National Institutes of Health, Lawton Chiles
International House, Bethesda, MD 20892.
Contact Person: Robert Eiss, Public Health Advisor, Fogarty
International Center, National Institutes of Health, 31 Center
Drive, Room B2C02, Bethesda, MD 20892, (301) 496-1415,
EISSR@MAIL.NIH.GOV.
This meeting is being published less than 15 days prior to the
meeting due to timing limitations imposed by administrative matters.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
drivers license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nih.gov/fic/about/advisory.html, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.106,
Minority International Research Training Grant in the Biomedical and
Behavioral Sciences; 93.154, Special International Postdoctoral
Research Program in Acquired lmmunodeficiency Syndrome; 93.168,
International Cooperative Biodiversity Groups Program; 93.934,
Fogarty International Research Collaboration Award; 93.989, Senior
International Fellowship Awards Program, National Institutes of
Health, HHS)
Dated: January 21, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-1753 Filed 1-27-09; 8:45 am]
BILLING CODE 4140-01-P
